Bioptimus has launched the Spatial Tissue Embedding Learning Atlas (STELA), a global initiative to profile up to 100,000 patient specimens across oncology and immunology tissues. This effort aims to generate the world's largest clinically linked, multimodal spatial biology dataset using advanced technologies like 10x Genomics' Xenium platform, integrating spatial transcriptomics, histopathology imaging, multi-omics, and clinical data. STELA will serve as the data foundation for Bioptimus' M-Optimus, the first world model of biology, enabling researchers to better understand disease mechanisms and accelerate precision medicine development. Strategic partnerships with 10x Genomics and Broad Clinical Labs ensure high-quality, large-scale data generation and AI-driven insights to transform biomedical research and patient care.
10x Genomics, a leader in life science technology, will announce its financial results for Q2 ended June 30, 2026, after market close on August 6, 2026. The company will hold a public conference call and live webcast at 1:30 p.m. PT to discuss its ea...
Torex Gold Resources announced positive drilling outcomes at its Morelos Complex, including the ELG Underground and Media Luna Cluster, indicating potential for significant resource expansion and extended mine life. High-grade mineralization was enco...
